Heart Disease in the UK 2026
Heart and circulatory disease — the umbrella term that encompasses coronary heart disease, heart failure, stroke, atrial fibrillation, vascular dementia, and a range of related conditions — remains one of the United Kingdom’s most devastating and costly health challenges in 2026, despite decades of genuine clinical progress. According to the British Heart Foundation’s Cardiovascular Disease Statistics Compendium, published in May 2026 and drawing on the most comprehensive dataset of its kind in the UK, more than 8 million people are currently living with a cardiovascular disease in the country — over 4 million males and over 4 million females — making it one of the most prevalent chronic condition categories in the entire NHS. Every three minutes, someone in the UK loses their life to cardiovascular disease. That is not a rhetorical flourish; it is a calculation from the BHF’s own January 2026 England factsheet, compiled from ONS 2024 mortality data, and it translates to approximately 170,000 deaths from cardiovascular disease in the UK every year — accounting for around one in four of all deaths.
What makes the 2026 UK heart disease statistics particularly important is the combination of progress and stagnation they reveal simultaneously. On one side of the ledger, the clinical record over the past four decades is genuinely remarkable: premature CVD death rates in England have fallen by more than 80% over the last 40 years, a reduction driven by BHF-funded research, advances in treating heart attacks and strokes, the decline in smoking, and improvements in the management of risk factors like high blood pressure and cholesterol. On the other side, progress has slowed significantly since 2011, and a new set of challenges — an ageing population carrying a growing burden of obesity, diabetes, and hypertension; persistent geographical and socioeconomic inequalities; NHS treatment backlogs; and rising numbers of people living with multiple long-term conditions — is driving cardiovascular disease up the NHS agenda in ways that demand urgent, systemic responses. Understanding the full picture of UK heart disease statistics in 2026 is essential for patients, clinicians, policymakers, and anyone with a heart.
Interesting Facts About Heart Disease in the UK in 2026
| # | Fact | Key Figure / Source |
|---|---|---|
| 1 | More than 8 million people are living with cardiovascular disease in the UK — over 4 million males and over 4 million females | BHF UK CVD Factsheet, January 2026 |
| 2 | Heart and circulatory diseases cause around 1 in 4 deaths in the UK — approximately 170,000 deaths per year | BHF UK CVD Factsheet, January 2026; ONS 2024 data |
| 3 | Every three minutes someone in the UK loses their life to cardiovascular disease | BHF England CVD Factsheet, January 2026 |
| 4 | Heart diseases cause around 1 in 6 deaths in the UK — approximately 110,000 deaths each year or one death every 5 minutes | BHF UK CVD Factsheet, January 2026 |
| 5 | Around 36,000 people under the age of 75 die from heart diseases in the UK each year — a leading cause of premature death | BHF UK CVD Factsheet, January 2026 |
| 6 | The total cost of CVD to the UK in 2021/22 was £29.021 billion — with direct costs of £16.620 billion and indirect costs of £12.402 billion | Shih (2025) Economic Burden of CVD in the UK, European Heart Journal – QCCO, cited BHF 2026 |
| 7 | There are around 1.4 million people alive in the UK who have survived a heart attack | BHF Facts and Figures; BHF England Factsheet, January 2026 |
| 8 | Around 100,000 people are admitted to hospital each year due to heart attacks in the UK — one every 5 minutes | BHF Facts and Figures, 2026 |
| 9 | More than 1 million people in the UK today have heart failure | BHF UK Facts and Figures, 2026 |
| 10 | More than 1.4 million people in England have been diagnosed with atrial fibrillation | BHF England CVD Factsheet, January 2026 |
| 11 | Stroke causes around 34,000 deaths in the UK each year and is the biggest cause of severe disability | BHF UK Facts and Figures, 2026 |
| 12 | Around 70% of the UK’s cardiovascular burden is associated with modifiable risk factors — which are often preventable | BHF UK CVD Factsheet, January 2026 |
| 13 | 7,500 deaths from cardiovascular disease in England each year are attributable to particulate matter air pollution | BHF England CVD Factsheet, December 2025 |
| 14 | 81% of people with CVD in the UK have at least one other long-term condition | BHF England CVD Factsheet, December 2025 |
| 15 | Premature CVD death rates in England have fallen by more than 80% over the past 40 years — yet progress has slowed since 2011 | BHF England CVD Challenge; BHF Statistics Compendium 2025 |
Source: British Heart Foundation UK CVD Factsheet (January 2026); BHF England CVD Factsheet (December 2025 / January 2026); BHF Facts and Figures for Journalists (2026); BHF Heart and Circulatory Disease Statistics Compendium (May 2026); Shih (2025) Economic Burden of Cardiovascular Disease in the UK, European Heart Journal — Quality of Care and Clinical Outcomes (Oxford Academic, February 2025); ONS Deaths Registered by Cause, Sex and Age, 2024 (via BHF)
The 15 headline facts above position heart and circulatory disease not as a solved problem but as an active, evolving public health challenge that demands sustained attention. The contrast between the 80% reduction in premature CVD deaths over 40 years and the slowdown since 2011 captures the central tension in UK cardiovascular health in 2026: the low-hanging fruit of smoking reduction and acute treatment improvement has been harvested, and the remaining drivers of cardiovascular burden — obesity, diabetes, sedentary lifestyles, air pollution, health inequalities, and an ageing population — are proving considerably harder to shift. When 81% of people with CVD have at least one other long-term condition, it means that cardiovascular care in 2026 is inseparable from the management of diabetes, chronic kidney disease, hypertension, and obesity — a complexity that single-condition clinical pathways were not designed to handle efficiently.
The £29.021 billion total cost of CVD to the UK economy in 2021/22 — derived from the most comprehensive cost-of-illness study published to date, by Shih et al. in the European Heart Journal in 2025 and cited directly in BHF’s 2026 factsheets — represents both a staggering burden and a powerful economic argument for prevention. The split between £16.620 billion in direct healthcare costs and £12.402 billion in indirect costs (including production losses to morbidity and mortality, and informal care costs) makes clear that CVD’s economic impact extends far beyond hospital budgets into the productive and social fabric of the country. The 7,500 deaths annually from cardiovascular disease attributable to air pollution in England alone adds an environmental justice dimension to the data: people living in high-pollution urban areas — who tend disproportionately to be from lower-income and minority ethnic communities — bear a pollution-mediated cardiovascular risk that compounds every other risk factor they face.
UK Cardiovascular Disease Prevalence by Condition in 2026 | Clinical Breakdown
CVD Conditions — People Living with Condition in UK (2026, BHF Data)
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
Total CVD (all conditions) ████████████████████████████████████████ 8 million+
Heart disease (UK total) ████████████████████████████████████████ ~5 million
CVD — England ████████████████████████████████████████ ~6.7 million (GBD data)
CHD — England ████████████████████████████████████ ~1.9 million
Heart failure — UK ████████████████████████████████ 1 million+
Atrial fibrillation — England ████████████████████████████████ 1.4 million+
Heart attack survivors — UK ████████████████████████████ ~1.4 million
Stroke / TIA survivors — Eng. ████████████████████████████ ~1.2 million
Diabetes (CVD risk) — UK ████████████████████████████████████████ 5.8 million (diagnosed + undiagnosed)
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
Scale: Each █ ≈ relative case burden
| CVD Condition | UK / England Prevalence | Key Characteristic |
|---|---|---|
| All cardiovascular disease (CVD) | 8 million+ (4M+ male; 4M+ female) | UK total; includes all heart/circulatory conditions |
| Heart disease (all types) | ~5 million in UK | Broad category; driven by CHD and heart failure |
| Coronary heart disease (CHD) | ~1.9 million in England | Most commonly diagnosed heart disease; leading cause of heart attack |
| Heart failure | More than 1 million in UK; ~700,000 diagnosed by GP in England | Progressive; high hospitalisation rate; mortality rivals many cancers |
| Atrial fibrillation (AF) | 1.4 million+ diagnosed in England | Most common heart rhythm disorder; major stroke risk; significant underdiagnosis |
| Heart attack survivors | ~1.4 million in UK alive today | 1.1 million in England; majority living with ongoing cardiovascular risk |
| Stroke / TIA survivors | ~1.2 million in England | Stroke: biggest cause of severe disability in the UK |
| Vascular dementia | At least 180,000 in UK | CVD-pathway form of dementia; linked to hypertension and stroke history |
| Out-of-hospital cardiac arrest (OHCA) | 30,000+ per year in England | Survival rate just 1 in 10; PADs used in under 10% of cases |
| Congenital heart disease | ~1–2% of the population may be affected | Estimated using 1–2% prevalence range; significant unmet care need |
| Diabetes (CVD risk condition) | 5.8 million (diagnosed + undiagnosed); 4.8 million diagnosed | 1 in 3 adults with CVD also has diabetes; powerful compounding risk factor |
Source: BHF UK CVD Factsheet (January 2026); BHF England CVD Factsheet (January 2026); BHF Facts and Figures (2026); BHF Heart and Circulatory Disease Statistics Compendium (May 2026); Global Burden of Disease (GBD) data cited by BHF; Diabetes UK 2025
The condition-by-condition prevalence breakdown reveals that cardiovascular disease in the UK in 2026 is not a single entity but a complex ecosystem of interrelated conditions, each with its own clinical trajectory, treatment pathway, and demographic profile. Coronary heart disease — the process by which coronary arteries narrow through atherosclerosis, causing angina and eventually heart attacks — remains the dominant diagnosis within the CVD category and the single biggest cause of premature death in the UK. But the heart failure epidemic developing alongside it deserves equal urgency: with more than 1 million people living with heart failure and hospitalisation rates that outpace many other chronic conditions, heart failure is placing a burden on NHS inpatient services that is growing year on year as the population ages and more people survive heart attacks only to develop weakened cardiac function in the years that follow.
The out-of-hospital cardiac arrest (OHCA) survival data — just one in ten surviving across England, with public access defibrillators (PADs) used in under 10% of cases — represents one of the clearest and most actionable data points in UK cardiovascular medicine in 2026. The survival rate for OHCA in the UK is meaningfully lower than in countries like Norway, Denmark, and Japan, where bystander CPR rates and public defibrillator availability are significantly higher. The technology to improve these outcomes — defibrillators, CPR training — is available and cost-effective; what is lacking is the deployment density, public awareness, and training penetration needed to activate it consistently. Early CPR and defibrillation can more than double the chances of OHCA survival, according to BHF — making the gap between current and achievable survival rates one of the most preventable sources of cardiovascular mortality in the country.
UK Heart Disease Deaths by Type & Region in 2026 | Mortality Data
CVD Mortality — UK Deaths by Type (BHF 2026 Data, Annual Figures)
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
All CVD deaths annually (UK) ████████████████████████████████████████ ~170,000 (1 in 4 all deaths)
Heart disease deaths (UK) ████████████████████████████████████████ ~110,000 (1 in 6 all deaths)
Stroke deaths (UK) ████████████████████████████████ ~34,000 per year
Premature CVD deaths (<75) UK ████████████████████████████████████████ ~36,000 per year
Premature CVD deaths (<75) Eng ████████████████████████████████████████ ~28,000 per year
Air pollution CVD deaths (Eng) ████████████████████ ~7,500 per year
Scotland CHD deaths ████████████████████████████████████████ Highest rate in UK
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
Scale: Each █ ≈ relative mortality burden
| Mortality Metric | Figure | Source |
|---|---|---|
| All CVD deaths annually (UK) | ~170,000 — approximately 1 in 4 of all UK deaths | BHF UK Factsheet, January 2026; ONS 2024 |
| Heart disease deaths (UK) | ~110,000 per year — 1 in 6 of all UK deaths | BHF UK Factsheet, January 2026 |
| CVD deaths per unit time | One every 3 minutes (all CVD); one every 5 minutes (heart disease) | BHF England Factsheet; BHF UK Factsheet |
| Premature deaths from heart disease (<75) — UK | ~36,000 per year | BHF UK Factsheet, January 2026 |
| Premature deaths from heart disease (<75) — England | ~28,000 per year (including ~19,000 from CHD alone) | BHF England Factsheet, January 2026 |
| Stroke deaths annually — UK | ~34,000 per year | BHF UK Facts and Figures |
| Premature CVD deaths as % of all premature deaths — England | 22% of all premature deaths in England — 33,700 per year | BHF England CVD Challenge |
| Air pollution CVD deaths — England | ~7,500 per year attributable to particulate matter | BHF England Factsheet, December 2025 |
| Regional variation — CHD deaths | Scotland and north of England have highest CHD death rates | BHF UK Factsheet, January 2026 |
| Age-standardised CVD death rate — UK (2023) | 118 per 100,000 (global average: 215 per 100,000) | BHF Global Factsheet, January 2026 |
| CHD — biggest premature killer | Single biggest cause of premature death (under 75) in the UK | BHF UK CVD Factsheet, January 2026 |
| CVD deaths vs. dementia (2024) | Dementia was #1 overall cause; heart disease remained #1 killer in men | Alzheimer’s Research UK, December 2025 |
Source: BHF UK CVD Factsheet (January 2026); BHF England CVD Factsheet (December 2025 / January 2026); BHF Facts and Figures (2026); BHF Global CVD Factsheet (January 2026); ONS Deaths Registered by Cause, Sex and Age, 2024; Alzheimer’s Research UK (December 2025); BHF England CVD Challenge page
The mortality data for UK heart disease in 2026 presents a picture of a country where cardiovascular disease remains a mass-mortality phenomenon despite dramatic clinical improvements. The 110,000 annual heart disease deaths — one every five minutes — is the number that drives most BHF communications, and rightly so: it is the equivalent of more than 300 people per day dying from conditions that share a broadly common set of modifiable risk factors. The 36,000 premature deaths from heart disease — in people under 75 — is the figure that most powerfully captures the preventable dimension of cardiovascular mortality: these are not people dying in the final years of a long life but people losing years, decades, and life stages they should have had. The fact that coronary heart disease is the single biggest cause of premature death in the UK — ahead of cancer, dementia, and every other condition — is a fact that deserves far wider public recognition than it receives.
The regional inequality data — with Scotland and the north of England carrying the highest CHD death rates in the UK — is one of the most persistent and damaging features of the cardiovascular health landscape in 2026. The gradient runs from north to south and from deprivation to affluence with a consistency that reflects decades of differential exposure to the major risk factors: higher smoking rates, higher obesity prevalence, lower access to quality primary care, greater exposure to air pollution, and lower rates of participation in cardiovascular screening and prevention programmes. The UK age-standardised CVD death rate of 118 per 100,000 compares favourably to the global average of 215 — but the internal UK variation means that some communities in Scotland and northern England have death rates far closer to the global average than to the UK’s own national figure.
UK Heart Disease Risk Factors & Prevention in 2026
Modifiable CVD Risk Factors — UK Prevalence (2026 BHF Data)
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
70% of CVD burden: modifiable ████████████████████████████████████████ Preventable share
Diabetes (UK total) ████████████████████████████████████████ 5.8 million (diag + undiag)
Diabetes (UK diagnosed) ████████████████████████████████████████ 4.8 million adults
High blood pressure (UK) ████████████████████████████████████████ ~14 million adults (BHF est.)
Overweight / obese adults (UK) ████████████████████████████████████████ ~64% of adults
Air pollution (CVD deaths) ████████████████████████████████ 7,500/yr England alone
Smoking (residual burden) ████████████████████████████████ Still major risk; declining
Serious mental illness (CVD) ████████████████████ Elevated risk; underrecognised
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
Scale: Each █ ≈ relative prevalence or risk contribution
| Risk Factor | UK Prevalence / Key Statistic | CVD Link |
|---|---|---|
| High blood pressure (hypertension) | ~14 million adults in the UK estimated to have hypertension | Leading modifiable risk factor for CHD, stroke, heart failure, and atrial fibrillation |
| Diabetes | 4.8 million diagnosed adults in the UK; 5.8 million total including undiagnosed | 1 in 3 adults with CVD has diabetes; damages blood vessel walls; strong MI and stroke risk |
| Overweight / obesity | ~64% of UK adults classified overweight or obese | Drives hypertension, diabetes, and dyslipidaemia — compounding CVD risk |
| Smoking | Declining but still significant; second-hand smoke risks persist | Major, well-established CVD risk; even 1–2 cigarettes per day substantially elevates risk |
| High cholesterol / dyslipidaemia | Widespread; familial hypercholesterolaemia affects ~1 in 250 | Core mechanism of coronary artery disease; statin therapy central to management |
| Air pollution (PM2.5) | 7,500 CVD deaths per year in England from particulate matter | Particularly affects those in urban areas; deprived communities bear disproportionate burden |
| Physical inactivity | Majority of UK adults fail to meet recommended activity guidelines | Independent CVD risk factor; exercise is protective across all major cardiovascular outcomes |
| Serious mental illness (SMI) | People with psychosis, schizophrenia, or bipolar disorder have elevated CVD risk | Metabolic side effects of medication + lifestyle factors; significantly underrecognised risk |
| Ethnicity | South Asian communities have higher CHD risk; Black communities have higher stroke and hypertension risk | Complex interaction of genetics, lifestyle, and socioeconomic factors |
| Deprivation / socioeconomic status | Strong inverse gradient; most deprived have highest CVD risk and worst outcomes | Concentrated in northern England, Wales, Scotland; structural inequalities persist |
| Air pollution: 70% modifiable burden | 70% of the UK’s total cardiovascular burden is associated with modifiable risk factors | BHF UK Factsheet; key public health prevention message |
Source: BHF UK CVD Factsheet (January 2026); BHF England CVD Factsheet (December 2025); Diabetes UK 2025; BHF Heart and Circulatory Disease Statistics Compendium (May 2026); Office for Health Improvement & Disparities (OHID); ONS; BHF England CVD Challenge
The risk factor profile of UK cardiovascular disease in 2026 contains one of the most important and actionable messages in all of public health: 70% of the UK’s cardiovascular burden is associated with modifiable risk factors. This is not a marginal proportion — it means that seven in every ten deaths, hospitalizations, and disability-adjusted life years from cardiovascular disease in the UK are, in principle, preventable through changes in individual behaviour, clinical management, and environmental policy. The hypertension burden of approximately 14 million adults is particularly significant because high blood pressure is simultaneously the most powerful modifiable risk factor for stroke, heart failure, atrial fibrillation, and coronary heart disease — and one of the conditions most amenable to cheap, effective medical treatment. Yet blood pressure detection, treatment, and control rates in the UK remain far below optimal levels, particularly in younger men and in more deprived communities where healthcare engagement is lower.
The diabetes-CVD link embedded in the UK risk factor data is one of the most clinically significant in 2026. With 4.8 million diagnosed diabetics and an estimated 5.8 million total (approximately 1 million undiagnosed), and with 1 in 3 adults with CVD also having diabetes, the two epidemics are deeply intertwined: diabetes damages the inner lining of blood vessels through mechanisms that accelerate atherosclerosis, increase thrombotic risk, and impair the heart muscle directly through diabetic cardiomyopathy. Management of CVD risk in people with diabetes requires a comprehensive, multi-factor approach — not just blood glucose control but rigorous blood pressure management, statin therapy, and lifestyle modification simultaneously. The fact that 81% of people with CVD have at least one other long-term condition — most commonly diabetes, hypertension, or chronic kidney disease — reflects this deeply interconnected disease landscape and explains why integrated, multi-condition care pathways are increasingly recognised as central to improving UK cardiovascular outcomes.
Disclaimer: The data research report we present here is based on information found from various sources. We are not liable for any financial loss, errors, or damages of any kind that may result from the use of the information herein. We acknowledge that though we try to report accurately, we cannot verify the absolute facts of everything that has been represented.
